Frisius Medisch Centrum
Quick facts
Phase 3 pipeline
- nitroglycerin iv
Nitroglycerin releases nitric oxide, which activates guanylate cyclase to relax vascular smooth muscle and dilate blood vessels.
Phase 1 pipeline
- Hydrochloorthiazide · Other
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Frisius Medisch Centrum
What is Frisius Medisch Centrum's pipeline?
Frisius Medisch Centrum has 1 drugs in Phase 3, 0 in Phase 2, 1 in Phase 1. Late-stage candidates include nitroglycerin iv.
Related
- Sector hub: All tracked pharma companies